title: A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
authors.affiliation: Pharmacy Service, Red de Salud Mental de Araba, Araba, Spain. unax.lertxundietxebarria@osakidetza.net
authors.forename: Unax
authors.initials: U
authors.lastname: Lertxundi
authors.forename: Pedro
authors.initials: P
authors.lastname: Sanchez
authors.forename: Rafael
authors.initials: R
authors.lastname: Hernandez
authors.forename: Edorta
authors.initials: E
authors.lastname: Elizagarate
mesh_terms: D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy; D010265:Paraproteinemias / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D014150:Antipsychotic Agents; D016179:Granulocyte Colony-Stimulating Factor; D003024:Clozapine